KRAS and hepatocellular carcinoma: Whereas K-Ras signaling enhances Gli1 transcriptional activity in pancreatic cancer [7], protein kinase C and PKA negatively regulate Gli1 by affecting its nuclear localization in hepatocellular carcinoma and NIH3T3 cells, respectively [12, 13].